2018 International Congress Archives - Page 57 of 177

Facial Movement Analysis in Parkinson’s disease: A decade of advances

W. Rattanachaisit, R. Bhidayasiri (Bangkok, Thailand)
Factors affecting quality of life in patients with Parkinson´s disease: Motor vs non-motor symptoms. Results from the COPPADIS Study Cohort

D. Santos, T. de Deus, C. Borrué, M. Mata, B. Solano Vila, A. Cots Foraster, M. Álvarez Sauco, A.B. Rodríguez Pérez, L. Vela, Y. Macías, S. Escalante, P. Estebe, S. Reverté, E. Cubo, E. Casas, S. Arnaiz, F. Carrillo Padilla, M. Pueyo, P. Mir, P. Martínez Martín, G. Coppadis Study (Ferrol, Spain)
Factors associated with Exercise Behaviour in Australians with Parkinson’s disease

D. Lee, N. Löfgren, J. Bampton, C. Canning, S. Paul (Lidcombe, Australia)
Factors associated with freezing of gait in patients with Parkinson’s disease

S.M. Choi, J.M. Kim, J.K. Lee, S.H. Kim, M.H. Park, K.W. Kang, K.H. Choi, J.T. Kim, S.H. Lee, M.S. Park, B. Kim, M.K. Kim (Gwangju, Republic of Korea)
Factors Associated with Non-adherence to Pharmacotherapy in Patients with Parkinson´s Disease Who Take Three and More Daily Doses of Dopaminergic Drugs

I. Straka, M. Škorvánek, M. Grofik, K. Danterová, M. Minár, J. Benetin, P. Valkovič (Bratislava, Slovakia)
Factors predicting patient satisfaction with botulinum toxin treatment in cervical dystonia patients who have been treated for a year

V. Misra, C. Colosimo, T. Chung, D. Charles, S. Om, P. Maisonobe (London, United Kingdom)
Falls in people with Parkinson’s disease: Results from a Multidisciplinary Movement Disorders Clinic in Singapore

D. Tan, S. Balakrishnan, A. Scully, P. Kumar (Singapore, Singapore)
Familial SCA2-parkinsonism presented as intractable oromandibular dystonia

K. Woo, B. Jeon, J. Lee (Seoul, Republic of Korea)
Fasciculations from a cholinesterase inhibitor

W. Deeb (Gainesville, FL, USA)
Fast paced gait may be more discriminating than dual tasking for detecting severity of gait and turn deficits in FXTAS

J. O'Keefe, D. Carnes, E. Robertson, T. Young, N. Purcell, E. Berry-Kravis, D. Hall (Chicago, IL, USA)
Fatigue and depression are predictors of the tremor form of Parkinson’s disease

E. Kolupaeva, I. Zhukova, M. Nikitina, N. Zhukova, A. Latypova, O. Izhboldina, I. Mironova, M. Zhestikova, M. Titova, J. Kislukhina (Tomsk, Russian Federation)
FDG-PET and metabolomics in PD-associated GBA variants

A. Greuel, JP. Trezzi, E. Glaab, C. Jäger, Z. Hodak, K. Lohmann, C. Klein, L. Timmermann, A. Drzezga, M. Tittgemeyer, Y. Ma, N. Diederich, C. Eggers (Marburg, Germany)
Feasibility and Efficacy of Brainstem Modulation Therapy for the Management of Parkinson’s Disease

K. Ade, A. Podlewska, T. Pellet-Higgins, S. Banducci, M. Bodani, M. Sakel, D. Wilkinson (Raleigh, NC, USA)
Feasibility aspects of evaluating neuroplastic changes after balance training in Parkinson´s disease: A pilot randomised controlled trial

H. Johansson, M. Hagströmer, U. Ekman, B. Leavy, M. Freidle, E. Schalling, P. Svenningsson, E. Franzén (Huddinge, Sweden)
Feasibility of a health game on cognition in Parkinson’s disease: Interim analyses of the Parkin’Play Study

S. vd Weijer, M. Kuijf, A. Duits, R. Kessels, N. de Vries, S. Köhler, G. Tissingh, B. Bloem (Maastricht, Netherlands)
Feasibility of a multi-sensor data fusion method for assessment of Parkinson’s disease motor symptoms

M. Memedi, S. Aghanavesi, D. Nyholm, F. Bergquist, M. Senek (Örebro, Sweden)
Final MDS-UPDRS, Part IV Results of the EASE LID 2 Study: Long Term, Open-Label Study of ADS-5102 for Dyskinesia in Parkinson’s disease (PD) patients

R. Hauser, R. Pahwa, C. Tanner, W. Oertel, R. Johnson, L. Felt, MJ. Stempien, R. Patni (Tampa, FL, USA)
Final Safety Results of EASE LID 2 Study: Long Term Open-Label Study of ADS-5102 for Dyskinesia in Parkinson’s disease (PD) patients

S. Isaacson, R. Pahwa, C. Tanner, R. Hauser, W. Oertel, R. Johnson, L. Felt, M.J. Stempien, R. Patni (Boca Raton, FL, USA)
Finger Tapping Profile in “On State” PD Patients

JP. Romero, I. Serrano, D. Del Castillo, A. Arroyo, V. Cortés, J. Andreo, J. Periañez, M. Rios (Madrid, Spain)
First Results from the Ixcellence Network® Survey: Botulinum Neurotoxin-A Usage and Training in Cervical Dystonia & Spastic Paresis

R. Bhidayasiri, K. Bahtia, L.J. Jacinto, TM. Chung, T. Landreau, C. Colosimo (Bangkok, Thailand)
Five Year Outcomes of a Prospective, Multicenter Trial Evaluating Deep Brain Stimulation with a New Multiple Source, Constant Current Rechargeable System in Parkinson’s Disease

L. Timmermann, R. Jain, N. Van Dyck, L. Chen, T. Brücke, F. Siejo, E. Suarez-San Martin, V. Visser-Vandewalle, M. Barbe, S. Gill, A. Whone, M. Porta, D. Servello, F. Alesch (Köln, Germany)
Flexed posture: Relationships with non-motor impairments and upper body activities in people with Parkinson’s disease

A. Forsyth, R. Joshi, N. Allen, C. Canning, S. Paul (Sydney, Australia)
Fluvoxamine maleate effects on dopamine signaling in the prefrontal cortex of stressed parkinsonian rats: Implications for learning and memory

E. Dalle, W. Daniels, M. Mabandla (Durban, South Africa)
Four eyelid and eye movement disorder cases misdiagnosed as seronegative ocular myasthenia gravis

M. Kamada, K. Kume (Kita-gun, Japan)
Fragile X-associated tremor/ataxia syndrome, Parkinson’s disease, and essential tremor subjects demonstrate distinct tremor characteristics using quantitative tremorography

E. Robertson, D. Hall, G. Pal, B. Ouyang, Y. Liu, A. McAsey, A. Bery, C. Huml, B. Bernard, E. Berry-Kravis, J. O'Keefe (Chicago, IL, USA)
Frailty in Patients with Parkinson’s Disease: Associations with Disability and Timed Up and Go Test

F. Fırat Ozer, S. Akın, M. Gultekin, G. Erturk, A. Ekinci (Kayseri, Turkey)
Free-living gait in REM sleep behaviour disorder: Measures of prodromal Parkinson’s disease?

S. Del Din, T. Barber, C. Lo, M. Rolinski, F. Baig, M. Hu, L. Rochester (Newcastle upon Tyne, United Kingdom)
Freezing of Gait in Parkinson’s Disease: Clinico-biochemical Observations

B. Mondal, R. Banerjee, K. Chatterjee, A. Roy, S. Shubham, P. Basu, S. Choudhury, H. Kumar (Kolkata, India)
Freezing of gait recognition in Parkinson’s disease: A subject independent objective method

V. Rama Raju (Hyderabad, India)
Frequency and Phenoptypic Spectrum of KMT2B Mutations in Childhood-Onset Dystonia: Results from a Single-Centre Cohort Study

M. Carecchio, G. Zorzi, F. Invernizzi, C. Panteghini, L. Romito, F. Zibordi, V. Leuzzi, S. Galosi, P. Morana, B. Morana, C. Piano, A. Bentivoglio, C. Reale, F. Girotti, M. Topf, A. Joseph, M. Kurian, S. Lubbe, B. Garavaglia, N. Mencacci, N. Nardocci (Milan, Italy)
Frequency of the LRRK2 and GBA mutations in Russian population with Parkinson’s disease

K. Senkevich, A. Emelyanov, M. Nikolaev, T. Usenko, A. Bezrukova, I. Miliukhina, A. Kopytova, A. Timofeeva, A. Yakimovsky, S. Pchelina (Saint-Petersburg, Russian Federation)
Frequency-dependent effects of subthalamic deep brain stimulation on motor symptoms in Parkinson’s disease

D. Su, W. Hu, H. Chen, J. Zhou, T. Feng (Beijing, China)
From Non-rechargeable to Rechargeable Technology: Insights and Management of Pallidal Deep Brain Stimulation in Dystonia after Switching to a Rechargeable Implantable Pulse Generator

M. Wolf, A. Saryyeva, D. Schulte, J. Krauss, C. Blahak (Mannheim, Germany)
Frontal midline theta activity is reduced during cognitive control in Parkinson’s disease

A. Singh, S. Richardson, N. Narayanan, J. Cavanagh (Iowa City, IA, USA)
Frontal-subcortical cognitive impairments in Parkinson’s patients with freezing of gait

J. Garcia-Caldentey, MA. Prats-Sedano, E. Estelrich-Peyret, PJ. Garcia-Ruiz (Palma de Mallorca, Spain)
Full sequencing and haplotype analysis reveals LRRK2 protective haplotype in REM sleep behavior disorder

B. Ouled Amar-Bencheikh, J. Ruskey, I. Arnulf, Y. Dauvilliers, C. Charley Monaca, V. Cochen De-Cock, JF. Gagnon, D. Spiegelman, M. Hu, B. Högl, A. Stefani, L. Ferini-Strambi, G. Plazzi, E. Antelmi, P. Young, A. Heidbreder, B. Mollenhauer, F. Sixel-Döring, C. Trenkwalder, W. Oertel, J. Montplaisir, R. Postuma, G. Rouleau, Z. Gan-Or (Montreal, QC, Canada)
Functional Balance and Neuromuscular Strength Difficulties Like Fracture Predictors in a Parkinsonian Population

L. Leandro, C. Moreira, H. Teive (Curitiba, Brazil)
Functional connectivity changes in relation to dopaminergic decline in Parkinson’s over time: A resting-state fMRI and 11C-PE2I PET imaging study

W. Li, N. Lao-Kaim, A. Roussakis, A. Martín-Bastida, N. Valle-Guzman, G. Paul, E. Soreq, R. Daws, T. Foltynie, R. Barker, A. Hampshire, P. Piccini (London, United Kingdom)
Functional Conundrum in Wilson’s Disease

S. Raju (Bengaluru, India)
Functional motor disorders phenotypes. Lumping or splitting?

J. Gelauff, J. Rosmalen, J. Stone, J. Gardien, M. Tijssen (Groningen, Netherlands)
FuRST2.0: Development of a modified functional rating scale for use in premanifest and early-manifest Huntington’s disease

R. Fuller, P. Feigenbaum, C. Fitzer-Attas, N. La Pelle, S. Luo, C. Sampaio, G. Stebbins (Princeton, NJ, USA)
Further insights into excitatory-inhibitory balance of the primary motor cortex in Parkinson’s disease: A triple-pulse stimulation study

Y. Shirota, Y. Terao, Y. Ugawa, R. Hanajima (Tokyo, Japan)
Future doctors as health educators: Undergraduate medical students raise awareness and unite for Parkinson’s disease

S. El-Jaafary, H. Amer, A. Fouad, B. Tawfiq, L. El Sabbahy, A. Bayoumy, B. Abulkarim, B. Gamal, H. Nafea, H. Shehata, M. El-Tamawy (Cairo, Egypt)
FXN and ATXN2 methylation profile in Friedreich’s ataxia and spinocerebellar ataxia type 2

E. Nuzhnyi, N. Abramycheva, T. Pogoda, S. Klyushnikov, M. Ershova, S. Illarioshkin, E. Fedotova (Moscow, Russian Federation)
FXTAS-like Phenotype with p.P626L Missense Mutation: A case report

X. Duan, L. Zhang, C. Liu, W. Liao, F. Tassone, Y. Yi, R. Hagerman (Shang Sha, China)